The global pen insulin syringe market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of diabetes and rising awareness about diabetes management. The increasing number of people suffering from diabetes is driving the demand for insulin syringes globally. Moreover, the growing number of diabetic patients in developing countries such as India and China is also contributing to the growth of this market. The reusable pens segment accounted for a share of over 50% in 2017 and are expected to continue their dominance throughout the forecast period owing to their cost-effectiveness and convenience in use. Disposable pens are expected to witness significant growth during the forecast period owing to their ease-of-use, which makes them more popular among patients with limited dexterity or those who have difficulty using reusable pens due to lack of access or affordability issues.
- Increasing prevalence of diabetes and obesity in developing countries is driving the growth of the global Pen Insulin Syringe market.
- Increasing awareness about diabetes and its complications among people is also driving the growth of the global Pen Insulin Syringe market.
- The increasing number of new product launches by major players in this industry is also driving the growth of this market.
- The high cost associated with insulin pens as compared to other types, such as vials, syringes, and cartridges, has been a major factor restraining the growth of this market.
Industry Growth Insights published a new data on “Pen Insulin Syringe Market”. The research report is titled “Pen Insulin Syringe Market research by Types (Reusable Pens, Disposable Pens), By Applications (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers), By Players/Companies Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon, Sanofi, Becton, Dickinson, Owen Mumford, Jiangsu Delfu, Wockhardt”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pen Insulin Syringe Market Research Report
By Type
Reusable Pens, Disposable Pens
By Application
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers
By Companies
Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon, Sanofi, Becton, Dickinson, Owen Mumford, Jiangsu Delfu, Wockhardt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Pen Insulin Syringe Market Report Segments:
The global Pen Insulin Syringe market is segmented on the basis of:
Types
Reusable Pens, Disposable Pens
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk A/S
- Eli Lilly and Company
- AstraZeneca plc
- Biocon
- Sanofi
- Becton, Dickinson
- Owen Mumford
- Jiangsu Delfu
- Wockhardt
Highlights of The Pen Insulin Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Pens
- Disposable Pens
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pen Insulin Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pen insulin syringe is a small, disposable device used to inject insulin.
Some of the major players in the pen insulin syringe market are Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon, Sanofi, Becton, Dickinson, Owen Mumford, Jiangsu Delfu, Wockhardt.
The pen insulin syringe market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pen Insulin Syringe Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pen Insulin Syringe Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pen Insulin Syringe Market - Supply Chain
4.5. Global Pen Insulin Syringe Market Forecast
4.5.1. Pen Insulin Syringe Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pen Insulin Syringe Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pen Insulin Syringe Market Absolute $ Opportunity
5. Global Pen Insulin Syringe Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pen Insulin Syringe Market Size and Volume Forecast by Type
5.3.1. Reusable Pens
5.3.2. Disposable Pens
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pen Insulin Syringe Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pen Insulin Syringe Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacy
6.3.2. Retail Pharmacy
6.3.3. Online Sales
6.3.4. Diabetes Clinics/ Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pen Insulin Syringe Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pen Insulin Syringe Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pen Insulin Syringe Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pen Insulin Syringe Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pen Insulin Syringe Demand Share Forecast, 2019-2026
9. North America Pen Insulin Syringe Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pen Insulin Syringe Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pen Insulin Syringe Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Sales
9.4.4. Diabetes Clinics/ Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pen Insulin Syringe Market Size and Volume Forecast by Type
9.7.1. Reusable Pens
9.7.2. Disposable Pens
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pen Insulin Syringe Demand Share Forecast, 2019-2026
10. Latin America Pen Insulin Syringe Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pen Insulin Syringe Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pen Insulin Syringe Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Sales
10.4.4. Diabetes Clinics/ Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pen Insulin Syringe Market Size and Volume Forecast by Type
10.7.1. Reusable Pens
10.7.2. Disposable Pens
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pen Insulin Syringe Demand Share Forecast, 2019-2026
11. Europe Pen Insulin Syringe Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pen Insulin Syringe Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pen Insulin Syringe Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacy
11.4.2. Retail Pharmacy
11.4.3. Online Sales
11.4.4. Diabetes Clinics/ Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pen Insulin Syringe Market Size and Volume Forecast by Type
11.7.1. Reusable Pens
11.7.2. Disposable Pens
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y rowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pen Insulin Syringe Demand Share, 2019-2026
12. Asia Pacific Pen Insulin Syringe Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pen Insulin Syringe Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pen Insulin Syringe Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacy
12.4.2. Retail Pharmacy
12.4.3. Online Sales
12.4.4. Diabetes Clinics/ Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pen Insulin Syringe Market Size and Volume Forecast by Type
12.7.1. Reusable Pens
12.7.2. Disposable Pens
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pen Insulin Syringe Demand Share, 2019-2026
13. Middle East & Africa Pen Insulin Syringe Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pen Insulin Syringe Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pen Insulin Syringe Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacy
13.4.2. Retail Pharmacy
13.4.3. Online Sales
13.4.4. Diabetes Clinics/ Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pen Insulin Syringe Market Size and Volume Forecast by Type
13.7.1. Reusable Pens
13.7.2. Disposable Pens
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pen Insulin Syringe Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pen Insulin Syringe Market: Market Share Analysis
14.2. Pen Insulin Syringe Distributors and Customers
14.3. Pen Insulin Syringe Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novo Nordisk A/S
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Eli Lilly and Company
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca plc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biocon
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sanofi
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Becton, Dickinson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Owen Mumford
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Jiangsu Delfu
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Wockhardt
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook